【24h】

Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease.

机译:血红素-α,细胞色素C氧化酶的血红素假体,在阿尔茨海默氏病中增加。

获取原文
获取原文并翻译 | 示例
           

摘要

Heme-a, is the heme prosthetic group of cytochrome c oxidase (COX), the terminal complex of the mitochondrial electron transport chain. We measured heme-a levels in postmortem brain tissue from nine patients diagnosed with dementia: Alzheimer's disease (AD) was the primary diagnosis in five, AD/diffuse Lewy body disease (DLBD) was diagnosed in two, DLBD was diagnosed in one, and DLBD (severe)/AD (mild) was diagnosed in one. Eight non-demented patients who died from non-neurological causes served as controls. When the primary diagnosis was AD (AD and AD/DLBD), levels of cerebral heme-a were increased almost two-fold on a protein basis compared to controls (p<0.001). Using perfused and non-perfused rats we showed that measured levels of cerebral heme-a were unaffected by the presence of blood in brain tissue. In mice we showed that levels of cerebral heme-a were unaffected by 24h of storage at 4 degrees C prior to freezing. These animal studies suggest that increased levels of cerebral heme-a in AD were not due to blood in postmortem brain or variation in postmortem interval.
机译:血红素-a是细胞色素c氧化酶(COX)的血红素修复基团,是线粒体电子传输链的末端复合物。我们测量了9名被诊断为痴呆症的患者的死后脑组织中的血红素a水平:阿尔茨海默氏病(AD)是五分之一的主要诊断,AD /弥漫性路易体病(DLBD)被诊断为两个,DLBD被诊断为一个,以及DLBD(严重)/ AD(轻度)被诊断为一体。八名因非神经系统原因死亡的非痴呆患者作为对照。当主要诊断为AD(AD和AD / DLBD)时,与对照相比,以蛋白质为基础,脑血红素a水平几乎增加了两倍(p <0.001)。使用灌注和未灌注的大鼠,我们证明了脑血红素a的测定水平不受脑组织中血液的存在的影响。在小鼠中,我们显示了在冻结之前在4摄氏度下储存24小时,血红素a的水平不受影响。这些动物研究表明,AD中脑血红素a水平的升高并非由于死后大脑中的血液或死后间隔的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号